Eberhart CG - Search Results

1

TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.

Maynard RE, Poore B, Hanaford AR, Pham K, James M, Alt J, Park Y, Slusher BS, Tamayo P, Mesirov J, Archer TC, Pomeroy SL, Eberhart CG, Raabe EH. Maynard RE, et al. Among authors: eberhart cg. Cancer Lett. 2021 Apr 28;504:137-145. doi: 10.1016/j.canlet.2021.02.001. Epub 2021 Feb 8. Cancer Lett. 2021. PMID: 33571541 Free PMC article.

2

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.

Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC. Eberhart CG, et al. Cancer. 2002 Jan 15;94(2):552-60. doi: 10.1002/cncr.10189. Cancer. 2002. PMID: 11900240 Free article.

3

Medulloblastoma growth inhibition by hedgehog pathway blockade.

Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, Beachy PA. Berman DM, et al. Among authors: eberhart cg. Science. 2002 Aug 30;297(5586):1559-61. doi: 10.1126/science.1073733. Science. 2002. PMID: 12202832

4

The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.

Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. Li Y, et al. Cancer Res. 2005 Oct 15;65(20):9355-62. doi: 10.1158/0008-5472.CAN-05-1946. Cancer Res. 2005. PMID: 16230398

5

c-myc overexpression causes anaplasia in medulloblastoma.

Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG. Stearns D, et al. Among authors: eberhart cg. Cancer Res. 2006 Jan 15;66(2):673-81. doi: 10.1158/0008-5472.CAN-05-1580. Cancer Res. 2006. PMID: 16423996

6

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.

Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. Fan X, et al. Among authors: eberhart cg. Cancer Res. 2006 Aug 1;66(15):7445-52. doi: 10.1158/0008-5472.CAN-06-0858. Cancer Res. 2006. PMID: 16885340

7

Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.

Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK. Lo KC, et al. Among authors: eberhart cg. Clin Cancer Res. 2007 Dec 1;13(23):7022-8. doi: 10.1158/1078-0432.CCR-07-1420. Clin Cancer Res. 2007. PMID: 18056178

8

Medulloblastoma stem cells.

Fan X, Eberhart CG. Fan X, et al. Among authors: eberhart cg. J Clin Oncol. 2008 Jun 10;26(17):2821-7. doi: 10.1200/JCO.2007.15.2264. J Clin Oncol. 2008. PMID: 18539960 Free PMC article. Review.

9

RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.

von Bueren AO, Shalaby T, Oehler-Jänne C, Arnold L, Stearns D, Eberhart CG, Arcaro A, Pruschy M, Grotzer MA. von Bueren AO, et al. Among authors: eberhart cg. BMC Cancer. 2009 Jan 10;9:10. doi: 10.1186/1471-2407-9-10. BMC Cancer. 2009. PMID: 19134217 Free PMC article.

10

High-risk medulloblastoma: does c-myc amplification overrule histopathology?

Raabe EH, Eberhart CG. Raabe EH, et al. Among authors: eberhart cg. Pediatr Blood Cancer. 2010 Mar;54(3):344-5. doi: 10.1002/pbc.22398. Pediatr Blood Cancer. 2010. PMID: 20063409 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page